XML 36 R12.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Acquisitions | 12 Months Ended
--- | ---
Dec. 31, 2017
Business Combinations [Abstract] |
Acquisitions | ACQUISITIONS In 2017 and 2016 total cash paid for acquisitions was $831 and $4,332. We acquired stock in companies and various assets that continue to support our capital deployment and product development strategies. In December 2017 we announced a definitive merger agreement to acquire Entellus Medical, Inc. (Entellus), a high-growth global medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of various ear, nose and throat (ENT) disease states, for $24.00 per share, or total consideration of approximately $662. Entellus, which had net sales of approximately $75 in 2016, will be integrated into the Instruments business within MedSurg. We expect the acquisition to close in February 2018. In September 2017 we completed the acquisition of NOVADAQ Technologies Inc. (NOVADAQ) for total consideration of approximately $716. NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures. This acquisition enhances product offerings within our MedSurg segment. Goodwill related to the NOVADAQ acquisition is not deductible for tax purposes.
Purchase Price Allocation of Acquired Net Assets
| 2017 |  | 2016
| NOVADAQ |  | Sage | Physio
Purchase price paid | $ | 716 |  |  | $ | 2,870 |  | $ | 1,299 |
Contingent consideration | — |  |  | 5 |  | — |
Total consideration | $ | 716 |  |  | $ | 2,875 |  | $ | 1,299 |
Tangible assets acquired:
Cash | 42 |  |  | 91 |  | 32 |
Accounts receivable | 11 |  |  | 29 |  | 107 |
Inventory | 39 |  |  | 63 |  | 61 |
Other assets | 9 |  |  | 80 |  | 103 |
Liabilities | (58 | ) |  | (83 | ) | (364 | )
Intangible assets: |  |  |  |
Customer relationship | 18 |  |  | 930 |  | 344 |
Trade name | 1 |  |  | 70 |  | 160 |
Developed technology and patents | 133 |  |  | 173 |  | 226 |
IPRD | — |  |  | — |  | 7 |
Goodwill | 521 |  |  | 1,522 |  | 623 |
| $ | 716 |  |  | $ | 2,875 |  | $ | 1,299 |
Weighted average life of intangible assets | 14 |  |  | 15 |  | 14 |
Purchase price allocations for NOVADAQ and other acquisitions in 2017 and 2016 were based on preliminary valuations. Our estimates and assumptions are subject to change within the measurement period. The purchase price allocation for the acquisitions of Sage Products, LLC (Sage) and Physio-Control International, Inc. (Physio) was finalized in 2017. Goodwill related to the Sage acquisition is deductible for tax purposes.

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI http://asc.fasb.org/topic&trid=2303972 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration